Maximizing 340B for Health Centers and Grantees

October 8, 2026

Participation in the federal 340B drug discount can provide essential savings and mission support to community health centers and other eligible federal grantees.  However, successful participation requires careful planning, strategic decision-making, and ongoing oversight. This one-hour webinar will help organizations evaluate how best to maximize the benefits of 340B participation based on their goals, patient population, pharmacy models, staffing capacity, vendor relationships, and ability to maintain meaningful oversight, as well as whether it is in the organization’s interests to expand or reduce 340B participation.  

The presenters will discuss key questions organizations should consider when evaluating 340B participation, both before establishing a program and throughout ongoing operations. They will provide an overview of the compliance issues that most commonly drive organizational risk, including patient eligibility, diversion, duplicate discounts, contract pharmacy arrangements, documentation requirements, and audit readiness. The training will also help attendees develop a practical decision-making framework that can be tailored to their organizations' unique needs, enabling them not only to understand the fundamentals of the 340B program but also to assess and implement operational strategies that best support their organizational goals and compliance obligations.

The on-demand version of this webinar will be available for purchase after the conclusion of the live webinar. 

Target Audience

  • CEOs/Directors
  • CFOs/Controllers/Fiscal Staff
  • Compliance Officers
  • Pharmacy Directors
  • Clinical Operations Directors
  • Grants Management Staff

Learning Objectives

After this webinar, you will be able to:

  1. Assess whether and how 340B participation best fits the organization’s goals, operations, pharmacy model, and compliance capacity
  2. Work through key decision points before starting, continuing, or expanding a 340B Program
  3. Understand the high-level compliance issues that most often create risk for covered entities
  4. Identify when additional planning, controls, staffing, or oversight may be needed before moving forward

Course summary

Available credit: 
  • 1.00 Certificate of Attendance
  • 1.20 CPE
Course opens: 
08/24/2026
Course expires: 
11/09/2026
Event starts: 
10/08/2026 - 1:00pm EDT
Event ends: 
10/08/2026 - 2:00pm EDT
Cost:
$185.00
Add to calendar: 

Andrea C. Harris

Andrea Harris serves as Counsel with the firm’s Health Care practice group, where she advises clients on complex compliance, contract and business strategy, employment, and FTCA-related matters. As a former General Counsel and Director of Corporate Compliance for a multi-site FQHC, Andrea brings firsthand insight into the regulatory, operational, and governance challenges health centers face. She partners closely with clients to navigate high-stakes issues and develop practical, strategic solutions. [Full Bio]

Steve Kuperberg

Steve Kuperberg is a Partner in the firm's Health Care and Litigation & Government Investigations practice groups. Steve regularly advises clients on issues related to the 340B drug discount program, health care fraud, contract disputes and the False Claims Act. An experienced litigator of over 25 years, he has represented many nonprofits in health care and education, such as 340B covered entities and their stakeholders, as well as government contractors. [Full Bio]

Participants can earn up to 1.20 CPE credits in Specialized Knowledge and Applications upon completion of all course requirements.

Attendee Requirements for CPE Credit

If you purchase CPE credit for this webinar you must satisfy the following conditions in order to receive your certificate:

  1. Answer at least 3 of the polling questions during the webinar
  2. Complete the evaluation survey after the conclusion of the webinar or in the follow-up email

Upon completion of these requirements, we will email you your CPE Certificate within two (2) weeks.

Additional Information

  • Prerequisites: None 
  • Target Audience: CEOs/Directors, CFOs/Controllers/Fiscal Staff, Compliance Officers, Pharmacy Directors, Clinical Operations Directors, and Grants Management Staff
  • Advanced Preparation: None  
  • Program Level: All
  • Delivery Method: Group Internet Based

Feldesman LLP is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website www.nasbaregistry.org (formerly www.learningmarket.org).

Available Credit

  • 1.00 Certificate of Attendance
  • 1.20 CPE

Price

Cost:
$185.00
Please login or register to take this course.

Access to the recorded version of this webinar is included in your purchase.

You will have access to the recordings for 180 days after enrollment. Once posted to your account, you can view each webinar anytime on-demand during the access period identified in your purchase confirmation. For additional information on viewing and accessing webinars, view our full terms and conditions here.

Payment Policy

We accept the following forms of payment: American Express, Mastercard, Visa, ACH, PayPal, electronic check, and check. For information about the methods of payment we accept, please review our Payment FAQs. 

Refunds/Cancellations

Review our Cancellation Policies.

Required Hardware/Software

Google Chrome and Mozilla Firefox are the preferred browsers.